908-359-8980 Menu

Improving the health of our patients through groundbreaking clinical research

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Clinical Trials:

Study: Injectable Treatment to Treat Keloids

Purpose: To assess the safety, tolerability, and efficacy of various doses of STP705 (10μg, 20μg, 30μg and 40μg) intradermal injection and placebo, when injected into the keloid excision site, to prevent the recurrence of keloids following their excision. The study treatments are administered once per week. There will be four (4) follow-up visits at one (1), three (3), six (6) and nine (9) months after your keloid surgery.

Qualifications:

  • Male and Females, 18 – 60 years old
  • Have at least one keloid scar present for at least one year on the upper body, arms, or legs

Duration: 54 weeks

Location: Hackensack, NJ

Compensation: Up to $1,100 if all study visits are completed

To participate Please click here.


Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis

Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.

Qualifications:

  • Male and Females, 18 years or older
  • Current diagnosis of Plaque Psoriasis

Duration: Up to 20 weeks

Location: Hackensack, NJ

Compensation: Up to $630 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Evaluation of Dermal Cooling System for the Treatment of Psoriasis

Purpose: The purpose of this investigation is to evaluate the Dermal Cooling System for the treatment of Psoriasis in adult subjects, to verify that exposure to controlled cold conditions will elicit improvement in the cosmetic appearance or physical symptoms of patients affected by this skin condition.

Qualifications:

  • Males and females, ages 18 or older
  • Psoriasis diagnosis (if no diagnosis, can be diagnosed on site)
  • Subject is willing to have skin exposed to cooling with Dermal Cooling System

Duration: Approximately 12 months

Location: Hackensack, NJ

Compensation: $50 per visit

Interested in participating in our clinical research study? Please click here.


Study: Efficacy and Safety study of RPT193 as Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis

Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.

Qualifications:

  • Male and Females, 18 to 75 years old
  • Clinical diagnosis of Atopic Dermatitis
  • Documented history of inadequate response to a ≥1 month treatment with topical medications

Duration: Up to 7 months

Location: Hackensack, NJ

Compensation: Up to $650

Interested in participating in our clinical research study? Please click here.


Study: A Post Market Study of a 1726nm Laser System for the Treatment of Acne Vulgaris

Purpose: The purpose of this investigation is to evaluate the safety and efficacy of the Cutera® 1726 nm laser system for the treatment of moderate to severe acne. Subjects will receive 3 laser treatments at 4-week intervals. Follow-up visits will occur at approximately 7 days post each treatment (via phone) and at 12-, 26- and 52-weeks post third treatment.

Qualifications:

  • Males and females, ages 16 to 60 years
  • Fitzpatrick skin types I-VI with moderate or severe acne vulgaris

Duration: Approximately 17 months

Location: Hackensack, NJ

Compensation: Up to $275 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Non-Treatment Study for Hip Dip Images

Hip Dip image for Research Study

Purpose: Participants will go through a 15-minute photo session of their Hip Dips at sponsor photography location. The images will be used for medical education or clinical research only.

Qualifications:

  • Females, ages 18 or older
  • BMI <27
  • No tattoos, prominent scarring, or excessive cellulite
  • Must be fully vaccinated

Duration: Approximately 15 minutes

Location: Parsippany, NJ

Compensation: $200

Interested in participating in our clinical research study? Please click here.

Interested in participating in our clinical research study? Please click here.

What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified provide

To learn more contact: Diana Aranzazu, [email protected], 609-219-5621

Schedule A Consultation

Contact Us

Skin Laser & Surgery Specials of NY & NJ is now a division of Schweiger Dermatology Group.

Practice Policy Update Regarding COVID-19

The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.

New safety policies for patients:

  • Patients will undergo screening questions and receive comprehensive instructions about our new policies prior to their appointment.
  • To minimize contact, we will offer patients virtual check in and check out.
  • Patients will be instructed to come to the office wearing a mask.
  • Patient temperatures will be checked via forehead scanners upon arrival to the office.
  • We have reorganized our offices to maximize social distancing and cleanliness, and we have altered workflows to allow patients to wait outside or in their cars until their exam room is ready. Patients will be contacted via text message or phone call when the provider is ready for the visit to begin.
  • We are asking for patients to arrive at their appointment alone. For children and adult patients who require a caretaker, one adult may accompany the patient.
  • Patients who are sick or have had exposures to COVID-19 will be rescheduled.
  • Offices will be cleaned and disinfected frequently throughout the day.
  • Teledermatology appointments remain available for patients who prefer to be seen virtually.

New safety policies for office & staff:

  • All of our staff have completed training on all new workflows and infection prevention measures.
  • All of our clinical staff will be wearing appropriate personal protective equipment (PPE) during patient encounters to include masks and eye protection.
  • Our exam rooms are sanitized before and after every patient visit.
  • All SLSS team members will be screened for symptoms and/or fever daily prior to coming to work.
BOOK NOW
Contact Us